, biomarkers for chronic rejection of renal allografts, Transplantation, vol.87, pp.1505-1513, 2009.
The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients, Transplantation, vol.95, pp.1218-1224, 2013. ,
Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response, Transplantation, vol.99, pp.77-85, 2015. ,
The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study, N Engl J Med, vol.330, pp.816-819, 1994. ,
Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study, Lancet, vol.338, pp.461-463, 1991. ,
Induced pluripotent stem cells: past, present, and future, Cell Stem Cell, vol.10, pp.678-684, 2012. ,
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation, Nat Biotechnol, vol.33, pp.845-852, 2015. ,
Generation of distal airway epithelium from multipotent human foregut stem cells, Stem Cells Dev, vol.24, pp.1680-1690, 2015. ,
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, pp.581-589, 2015. ,
DOI : 10.1016/j.jhep.2014.10.016
URL : https://doi.org/10.1016/j.jhep.2014.10.016
TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors, Nat Cell Biol, vol.17, pp.615-626, 2015. ,
Human pluripotent stem cells for modelling human liver diseases and cell therapy, Curr Gene Ther, vol.13, pp.120-132, 2013. ,
Vascularized and functional human liver from an iPSC-derived organ bud transplant, Nature, vol.499, pp.481-484, 2013. ,
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant, Nat Protoc, vol.9, pp.396-409, 2014. ,
Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases, Curr Gene Ther, vol.13, pp.139-151, 2013. ,
Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients, Stem cell reports, vol.4, pp.860-872, 2015. ,
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies, Lancet, vol.385, pp.509-516, 2015. ,
Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?, Biotechnol J, vol.9, pp.28-38, 2014. ,
Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo, Nat Biotechnol, vol.20, pp.467-472, 2002. ,
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells, Nat Biotechnol, vol.23, pp.69-74, 2005. ,
Proof of principle for transfusion of in vitro-generated red blood cells, Blood, vol.118, pp.5071-5079, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00692474
Bio-engineered and native red blood cells from cord blood exhibit the same metabolomic profile, Haematologica, vol.101, pp.220-222, 2016. ,
Deriving blood stem cells from pluripotent stem cells for research and therapy, Best Pract Res Clin Haematol, vol.27, pp.293-297, 2014. ,
Lost in translation: pluripotent stem cell-derived hematopoiesis, EMBO Mol Med, vol.7, pp.1388-1402, 2015. ,
Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine, Haematologica, vol.95, pp.1651-1659, 2010. ,
Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model, Haematologica, vol.97, pp.1795-1803, 2012. ,
Molecular signature of erythroblast enucleation in human embryonic stem cells, Stem Cells, vol.33, pp.2431-2441, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01515305
Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors, Cell Stem Cell, vol.13, pp.459-470, 2013. ,
Reprogramming human endothelial cells to haematopoietic cells requires vascular induction, Nature, vol.511, pp.312-318, 2014. ,
DOI : 10.1038/nature13547
URL : http://europepmc.org/articles/pmc4159670?pdf=render
Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy, Regen Med, vol.10, pp.275-286, 2015. ,
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells, Gene Ther, vol.19, pp.1035-1040, 2012. ,
Superior antigen crosspresentation and XCR1 expression define human CD11c + CD141+ cells as homologues of mouse CD8+ dendritic cells, J Exp Med, vol.207, pp.1273-1281, 2010. ,
New cell sources for T cell engineering and adoptive immunotherapy, Cell Stem Cell, vol.16, pp.357-366, 2015. ,
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy, Nat Biotechnol, vol.31, pp.928-933, 2013. ,
Development and applications of CRISPRCas9 for genome engineering, Cell, vol.157, pp.1262-1278 ,
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity, Blood, vol.113, pp.6094-6101, 2009. ,
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms, J Virol, vol.85, pp.43-50, 2011. ,
DOI : 10.1128/jvi.01774-10
URL : https://jvi.asm.org/content/85/1/43.full.pdf
Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy, Stem Cells Transl Med, vol.2, pp.274-283, 2013. ,
Induced pluripotent stem cellderived natural killer cells for treatment of ovarian cancer, Stem Cells, vol.34, pp.93-101, 2016. ,
Human mesenchymal stromal cells modulate T-cell responses through TNF-?-mediated activation of NF-kB, Eur J Immunol, vol.44, pp.480-488, 2014. ,
Glucocorticoidinduced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis, Arthritis Rheumatol, vol.67, pp.1514-1524, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01834130
PPAR?/? directs the therapeutic potential of mesenchymal stem cells in arthritis, Ann Rheum Dis, vol.75, pp.2166-2174, 2016. ,
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression, Toxicol Sci, vol.105, pp.418-428, 2008. ,
Emerging roles of PPARs in inflammation and immunity, Nat Rev Immunol, vol.2, pp.748-759, 2002. ,
PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells, Eur J Pharmacol, vol.435, pp.143-151, 2002. ,
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial, Int J Cardiol, vol.209, pp.258-265, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01269644
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair, Circulation, vol.122, pp.2419-2429, 2010. ,
Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells, Cell Transplant, vol.20, pp.1547-1559, 2011. ,
The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia, Cytotherapy, vol.11, pp.427-434, 2009. ,
Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo, Regen Med, vol.10, pp.305-315, 2015. ,
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroidrefractory, grade III-IV acute graft-versus-host disease, Br J Haematol, vol.163, pp.501-509, 2013. ,
The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graftversus-host disease represent a death knell or a bump in the road?, Cytotherapy, vol.15, pp.2-8, 2013. ,
Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease, Clin Exp Immunol, vol.172, pp.333-348, 2013. ,
Ocular immune privilege: therapeutic opportunities from an experiment of nature, Nat Rev Immunol, vol.3, pp.879-889, 2003. ,
The taming of the shrew? The immunology of corneal transplantation, Acta Ophthalmol, vol.87, pp.488-497, 2009. ,
Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation, Am J Transplant, vol.14, pp.2023-2036, 2014. ,
Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model, Exp Eye Res, vol.102, pp.44-49, 2012. ,
Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation, Invest Ophthalmol Vis Sci, vol.55, pp.6631-6638, 2014. ,
Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo-and autoimmunity in the eye, Proc Natl Acad Sci, vol.113, pp.158-163, 2016. ,
Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response, Mol Ther, vol.20, pp.2143-2152, 2012. ,
An effective approach to prevent immune rejection of human ESC-derived allografts, Cell Stem Cell, vol.14, pp.121-130, 2014. ,
Immunogenicity of induced pluripotent stem cells, Nature, vol.474, pp.212-215, 2011. ,
Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts, PLoS One, vol.9, p.114949, 2014. ,
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, vol.494, pp.100-104, 2013. ,
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells, Cell Stem Cell, vol.12, pp.407-412, 2013. ,
To be immunogenic, or not to be: that's the iPSC question, Cell Stem Cell, vol.12, pp.385-386, 2013. ,
Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells, Cell Stem Cell, vol.17, pp.353-359, 2015. ,
Modeling disease in human ESCs using an efficient BAC-based homologous recombination system, Cell Stem Cell, vol.6, pp.80-89, 2010. ,
Differential functional effects of biomaterials on dendritic cell maturation, Acta Biomater, vol.8, pp.3606-3617, 2012. ,
Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells, J Biomed Mater Res A, vol.103, pp.170-184, 2015. ,
Co-stimulatory blockade of the CD28/ CD80-86/CTLA-4 balance in transplantation: impact on memory T cells?, Front Immunol, vol.6, p.411, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148498
Selective CD28 antagonist blunts memory immune responses and promotes long-term control of skin inflammation in nonhuman primates, J Immunol, vol.196, pp.274-283, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150299
Clinical efficacy of a new CD28-targeting antagonist of Tcell co-stimulation in a non-human primate model of collagen-induced arthritis, Clin Exp Immunol, vol.183, pp.405-418, 2016. ,
Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis, J Immunol, vol.194, pp.1454-1466, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148517
FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft, Am J Transplant, vol.15, pp.88-100, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148443
Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+))-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates, Clin Exp Immunol, vol.164, pp.265-274, 2011. ,